03816nam 22010213a 450 991036756670332120250203235429.09783039214266303921426810.3390/books978-3-03921-426-6(CKB)4100000010106079(oapen)https://directory.doabooks.org/handle/20.500.12854/59967(ScCtBLL)964cbf4c-ee40-4f76-8916-7f291bfea151(OCoLC)1163817977(oapen)doab59967(EXLCZ)99410000001010607920250203i20192019 uu engurmn|---annantxtrdacontentcrdamediacrrdacarrierStaphylococcus aureus ToxinsWilliam SchwanMDPI - Multidisciplinary Digital Publishing Institute2019Basel, Switzerland :MDPI,2019.1 electronic resource (204 p.)9783039214259 303921425X Staphylococcus aureus is a common inhabitant of the human body with which we co-exist. However, this species can also cause disease in humans when an appropriate opportunity arises, such as a cut or some other breakdown in our body's defenses. S. aureus is able to initiate infections due, in part, to the diverse group of toxins that they secrete. The exotoxins produced by S. aureus can cause direct damage, thwart our own body's defenses, or trigger massive amounts of cytokines that lead to indirect damage within the human body. In this book are 12 research articles that deal with different aspects of staphylococcal exotoxins. Some of the work gives an overview about how the toxins contribute to the disease process. Other articles discuss different aspects of several exotoxins, and two articles are centered on countermeasures against S. aureus infections. Overall, this book will give the reader a good overview of how staphylococcal exotoxins contribute to initiating and sustaining infections in humans.Biology, life sciencesbicsscHigBAcell physiologyairway epithelial cellsPPIaseatopic dermatitisadaptive immunitystaphylococcal enterotoxinsortase Acanned meatinhibitorinnate immunitylow cytotoxic strainsStaphylococcus aureusin vivo modelstoxin neutralizationenterotoxinLukGHPSMsmicrobiomeeyemolecular mechanismchronic infectiongene regulationtoxinsalpha-toxinsuperantigen-like proteinfermentationerianinPpiBHACCPinfectionenzymesmethicillin-resistant Staphylococcus aureusvirulence factorenterotoxinsmouse abscesstoxin-antitoxin systemsS. aureuspolyclonal antibodydefined minimal mediummastitisbutyric acid derivativeLukABtoxoid vaccinesuperantigenpathogenicity islandsPrsAsphingomyelinLeukocidinlux fusionBiology, life sciencesSchwan William1326364ScCtBLLScCtBLLBOOK9910367566703321Staphylococcus aureus Toxins3037381UNINA03482nam 2200949z- 450 991055735360332120220111(CKB)5400000000042354(oapen)https://directory.doabooks.org/handle/20.500.12854/76993(oapen)doab76993(EXLCZ)99540000000004235420202201d2021 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierBioactive Compounds from Brown AlgaeBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20211 online resource (188 p.)3-0365-2468-1 3-0365-2469-X Brown algae comprise approx. 2040 species grown in various climatic conditions. They represent a reservoir of various bioactive compounds, including fucoidan, alginate, phlorotannins, and fucoxanthins. They have shown an array of applications in pharmaceutical and medical fields. Hence, the Guest Editor invites all interested authors to submit their contributions to the current issue in Marine Drugs entitled "Bioactive Compounds from Brown Algae". It aims to highlight different aspects of bioactive compounds found in brown algae, in either research or review articles. Specifically, we are interested in downstream processes, chemistry, biotechnology, and applications of, for example, heteropolysaccharides and other brown algae bioactives. In addition, the structure elucidation and enzymatic modification of these components are also within the scope of the present Issue.Medicine and Nursingbicssc7-phloro-eckolalginateanti-inflammatoryanti-lung cancerantifungalantioxidantapoptosisastrocytesbioaccessibilitybioactivitybiological activitiesbrown algaebrown seaweedscancercoastal areacrude lipid extractDictyosiphon foeniculaceusdieckolfucoidanfucoidanasesfucoidansgastrointestinal tractgene expressionglioblastomaglycosidic linkagesgut microbiotahearing losshepatic steatosisHepG2/CYP2E1 cellshuman lung carcinoma A-549 cellslaminarinlarvicidallipogenesismolecular massesNMRnoiseoversulfationoxidative stressPFF-Aphlorotanninspolyphenolprebioticsretinal pigment epitheliumSargassum aquifoliumSargassum ilicifoliumseaweedshort-chain fatty acidsstructure-activity relationshipstoxicityuveal melanomaVEGFMedicine and NursingUlber Rolandedt1297563Ulber RolandothBOOK9910557353603321Bioactive Compounds from Brown Algae3024549UNINA